Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Is excision biopsy of fibroadenomas based solely on size criteria warranted?

Neville G, Neill CO, Murphy R, Corrigan M, Redmond PH, Feeley L, Bennett MW, O'Connell F, Browne TJ.

Breast J. 2018 Nov;24(6):981-985. doi: 10.1111/tbj.13069. Epub 2018 May 25.

PMID:
29802656
2.

Proliferative myositis of the latissimus dorsi presenting in a 20-year-old male athlete.

McHugh N, Tevlin R, Beggan C, Ryan DJ, Larkin J, Moloney F, Bennett MW, Kelly J.

Ir Med J. 2017 Aug 8;110(7):605.

PMID:
29341517
3.

Nerve infiltration by benign biliary glands - a diagnostic dilemma.

Ryan C, Conlon N, Bennett MW, Heffron CCBB.

Histopathology. 2018 Feb;72(3):525-527. doi: 10.1111/his.13372. Epub 2017 Nov 27. No abstract available.

PMID:
28851091
4.

When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.

Fives C, O'Neill CJ, Murphy R, Corrigan MA, O'Sullivan MJ, Feeley L, Bennett MW, O'Connell F, Browne TJ.

Breast. 2016 Dec;30:125-129. doi: 10.1016/j.breast.2016.09.006. Epub 2016 Oct 4.

PMID:
27718416
5.

PATI: Patient accessed tailored information: A pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application.

Foley NM, O'Connell EP, Lehane EA, Livingstone V, Maher B, Kaimkhani S, Cil T, Relihan N, Bennett MW, Redmond HP, Corrigan MA.

Breast. 2016 Dec;30:54-58. doi: 10.1016/j.breast.2016.08.012. Epub 2016 Sep 6.

PMID:
27611236
6.

Optimal Scoring of Brightfield Dual-Color In Situ Hybridization for Evaluation of HER2 Amplification in Breast Carcinoma: How Many Cells Are Enough?

Prendeville S, Corrigan MA, Livingstone V, Feeley L, Bennett MW, Browne TJ, O'Connell F.

Am J Clin Pathol. 2016 Mar;145(3):316-22. doi: 10.1093/ajcp/aqw017.

PMID:
27124913
7.
8.

An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.

O'Donnell C, Mahmoud A, Keane J, Murphy C, White D, Carey S, O'Riordain M, Bennett MW, Brint E, Houston A.

Br J Cancer. 2016 Jan 12;114(1):37-43. doi: 10.1038/bjc.2015.433. Epub 2015 Dec 17.

9.

An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions.

Foley NM, Racz JM, Al-Hilli Z, Livingstone V, Cil T, Holloway CM, Romics L Jr, Matrai Z, Bennett MW, Duddy L, Nofech-Mozes S, Slodkowska E, Mallon EA, Dawson N, Roche T, Relihan N, Hill AD, Redmond HP, Corrigan MA.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S385-90. doi: 10.1245/s10434-015-4773-z. Epub 2015 Aug 4.

PMID:
26240010
10.

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.

Prendeville S, Ryan C, Feeley L, O'Connell F, Browne TJ, O'Sullivan MJ, Bennett MW.

Breast. 2015 Jun;24(3):197-200. doi: 10.1016/j.breast.2015.01.004. Epub 2015 Feb 11.

PMID:
25681861
11.

Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic?

Kelly CM, El Bassiouni M, Bennett MW, Crush L, McEneaney P, O'Suilleabhain C, Power DG.

Acta Oncol. 2014 Sep;53(9):1268-71. doi: 10.3109/0284186X.2014.887856. Epub 2014 Apr 16. No abstract available.

PMID:
24739060
12.

Arsenic control during aquifer storage recovery cycle tests in the Floridan Aquifer.

Mirecki JE, Bennett MW, López-Baláez MC.

Ground Water. 2013 Jul-Aug;51(4):539-49. doi: 10.1111/j.1745-6584.2012.01001.x. Epub 2012 Oct 25.

PMID:
23106789
13.

Not again! The non-cycling blood pressure cuff.

Norris A, Bennett MW.

Anaesthesia. 2010 Nov;65(11):1142; discussion 1142. doi: 10.1111/j.1365-2044.2010.06516.x. No abstract available.

14.

Contribution to neural and mesodermal lineages by porcine skin-derived progenitors (SKPs) in vivo.

Zhao MT, Bennett MW, Zhang X, Spate L, Whitworth KM, Murphy CN, Rieke A, Zhang Y, Prather RS.

Cell Cycle. 2010 May 15;9(10):2040-1. Epub 2010 May 15. No abstract available.

15.

Porcine oocytes denuded before maturation can develop to the blastocyst stage if provided a cumulous cell-derived coculture system.

Zhang X, Miao Y, Zhao JG, Spate L, Bennett MW, Murphy CN, Schatten H, Prather RS.

J Anim Sci. 2010 Aug;88(8):2604-10. doi: 10.2527/jas.2009-2714. Epub 2010 Apr 9.

PMID:
20382876
16.

Cylindroma of the breast: a case report and review of the literature.

Mahmoud A, Hill DH, O'Sullivan MJ, Bennett MW.

Diagn Pathol. 2009 Sep 2;4:30. doi: 10.1186/1746-1596-4-30.

17.

Endometrial and cervical polyps in 22 baboons (Papio sp.), 5 cynomolgus macaques (Macaca fascicularis) and one marmoset (Callithrix jacchus).

Bennett MW, Dick EJ Jr, Schlabritz-Loutsevitch NE, Lopez-Alvarenga JC, Williams PC, Sharp RM, Hubbard GB.

J Med Primatol. 2009 Aug;38(4):257-62. doi: 10.1111/j.1600-0684.2009.00350.x. Epub 2009 Mar 5.

18.

Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations.

Liegl B, Bennett MW, Fletcher CD.

Am J Surg Pathol. 2008 Jul;32(7):1080-7. doi: 10.1097/PAS.0b013e318160cfda.

PMID:
18520439
19.

Ewing's sarcoma metastasis to the gastric wall in a 72-year-old patient.

Dodis LB, Bennett MW, Carr-Locke DL.

MedGenMed. 2006 Jul 10;8(3):6. No abstract available.

20.

Bcl-x(L) expression in vivo in rheumatoid synovium.

Busteed S, Bennett MW, Molloy C, Houston A, Stone MA, Shanahan F, Molloy MG, O'Connell J.

Clin Rheumatol. 2006 Nov;25(6):789-93. Epub 2006 Mar 30.

PMID:
16572289
21.

Faulty Penlon circle absorber.

Bennett MW, Nowicki RW.

Anaesthesia. 2005 Sep;60(9):932-3; discussion 933. No abstract available.

22.

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.

Sheil B, McCarthy J, O'Mahony L, Bennett MW, Ryan P, Fitzgibbon JJ, Kiely B, Collins JK, Shanahan F.

Gut. 2004 May;53(5):694-700. Erratum in: Gut. 2004 Aug;53(8):1216.

23.

Change of datasheet for ketorolac.

Knaggs R, Bennett MW.

Anaesthesia. 2004 Mar;59(3):305; discussion 305. No abstract available.

24.

Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis.

O'Connor TM, O'Connell J, O'Brien DI, Bennett MW, Goode T, Burke L, Bredin CP, Shanahan F.

J Clin Immunol. 2003 Sep;23(5):425-35.

PMID:
14601651
25.

Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.

Houston A, Bennett MW, O'Sullivan GC, Shanahan F, O'Connell J.

Br J Cancer. 2003 Oct 6;89(7):1345-51.

26.

Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants.

Alloway RR, Isaacs R, Lake K, Hoyer P, First R, Helderman H, Bunnapradist S, Leichtman A, Bennett MW, Tejani A, Takemoto SK.

Am J Transplant. 2003 Oct;3(10):1211-5.

27.

Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.

Houston A, Waldron-Lynch FD, Bennett MW, Roche D, O'Sullivan GC, Shanahan F, O'Connell J.

Int J Cancer. 2003 Nov 1;107(2):209-14.

28.

PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection.

Ryan P, Bennett MW, Aarons S, Lee G, Collins JK, O'Sullivan GC, O'Connell J, Shanahan F.

Gut. 2002 Nov;51(5):665-70.

29.

Rapid development of a quantitative-competitive (qc) RT-PCR assay using a composite primer approach.

O'Connell J, Houston A, Kelly R, O'Brien D, Ryan A, Bennett MW, Nally K.

Methods Mol Biol. 2002;193:93-102. No abstract available.

PMID:
12325528
30.

Mycobacterium paratuberculosis detected by nested PCR in intestinal granulomas isolated by LCM in cases of Crohn's disease.

Ryan P, Aarons S, Bennett MW, Lee G, O'Sullivan GC, O'Connell J, Shanahan F.

Methods Mol Biol. 2002;193:205-11. No abstract available.

PMID:
12325511
31.

The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of cIAP1 and 2.

Ruemmele FM, Beaulieu JF, O'Connell J, Bennett MW, Seidman EG, Lentze MJ.

Biochem Biophys Res Commun. 2002 Feb 1;290(4):1308-14.

PMID:
11812006
32.

Fas ligand upregulation is an early event in colonic carcinogenesis.

Bennett MW, O'Connell J, Houston A, Kelly J, O'Sullivan GC, Collins JK, Shanahan F.

J Clin Pathol. 2001 Aug;54(8):598-604.

33.

Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis--a putative role in pouchitis?

Coffey JC, Bennett MW, Wang JH, O'Connell J, Neary P, Shanahan F, Redmond HP, Kirwan WO.

J Surg Res. 2001 Jun 1;98(1):27-32.

PMID:
11368534
34.

Immune privilege or inflammation? Insights into the Fas ligand enigma.

O'Connell J, Houston A, Bennett MW, O'Sullivan GC, Shanahan F.

Nat Med. 2001 Mar;7(3):271-4.

PMID:
11231613
35.

Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis.

O'Connell J, Bennett MW, Nally K, O'Sullivan GC, Collins JK, Shanahan F.

J Cell Physiol. 2000 Dec;185(3):331-8.

PMID:
11056003
36.

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F.

Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. Review.

PMID:
10911913
37.

Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover.

Bennett MW, O'Connell J, O'Sullivan GC, Roche D, Brady C, Collins JK, Shanahan F.

Dis Esophagus. 1999;12(2):90-8.

PMID:
10466040
38.

Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F.

Dis Esophagus. 1999;12(2):83-9. Review.

PMID:
10466039
39.

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.

O'Connell J, Bennett MW, O'Sullivan GC, O'Callaghan J, Collins JK, Shanahan F.

Clin Diagn Lab Immunol. 1999 Jul;6(4):457-63.

40.

Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.

O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK, Shanahan F.

J Pathol. 1998 Nov;186(3):240-6.

PMID:
10211111
41.

Fas counter-attack--the best form of tumor defense?

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F.

Nat Med. 1999 Mar;5(3):267-8. No abstract available.

PMID:
10086376
42.

The Fas counterattack: cancer as a site of immune privilege.

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F.

Immunol Today. 1999 Jan;20(1):46-52. Review. No abstract available.

PMID:
10081230
43.

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.

Bennett MW, O'connell J, O'sullivan GC, Roche D, Brady C, Kelly J, Collins JK, Shanahan F.

Gut. 1999 Feb;44(2):156-62.

44.

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.

J Immunol. 1998 Jun 1;160(11):5669-75.

45.

The Fas counterattack: a molecular mechanism of tumor immune privilege.

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F.

Mol Med. 1997 May;3(5):294-300. Review. No abstract available.

46.

The use of thoracic epidural anesthesia in repair of an aortic coarctation.

Bennett MW, Cheema SP, Entress AH, Bellamy MC.

J Cardiothorac Vasc Anesth. 1995 Apr;9(2):174-6. No abstract available.

PMID:
7780074
48.
49.

Alterations in plasma magnesium concentrations during liver transplantation.

Bennett MW, Webster NR, Sadek SA.

Transplantation. 1993 Oct;56(4):859-61.

PMID:
8212207
50.

Percutaneous tracheostomy.

Bennett MW, Bodenham AR.

Clin Intensive Care. 1993;4(6):270-5. Review.

PMID:
10146664

Supplemental Content

Loading ...
Support Center